Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CUE | AMGN | BMY | VRTX | GILD |
| Company | Cue Biopharma Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.0100 | 290.84 | 58.35 | 454.30 | 89.81 |
| High | 1.0800 | 295.48 | 58.79 | 457.54 | 90.49 |
| Low | 1.0100 | 288.78 | 57.62 | 449.04 | 89.27 |
| Last | 1.0650 | 295.01 | 58.69 | 452.29 | 90.29 |
| Change | +0.0350 | +5.11 | +0.46 | +1.92 | +0.53 |
| % Change | +3.40% | +1.76% | +0.79% | +0.43% | +0.59% |
| Volume | 162,898 | 1,592,371 | 4,218,727 | 798,924 | 2,061,687 |
| 20-Day Average Volume | 705,474 | 2,916,969 | 12,246,679 | 1,333,788 | 7,341,884 |
| Previous Close | 1.0300 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4940 | 306.29 | 56.26 | 477.92 | 90.96 |
| 20-Day Raw Stochastic | 5.62% | 35.96% | 73.25% | 8.49% | 32.96% |
| 20-Day Relative Strength | 43.75% | 40.12% | 61.55% | 41.30% | 54.77% |
| Weighted Alpha | -77.05 | +4.15 | +27.15 | +18.42 | +27.12 |
| Today's Opinion | 8% Sell | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 8% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 24% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.46% since 11/15/24 | +3.84% since 11/15/24 | +4.23% since 11/15/24 | -3.08% since 11/15/24 | +2.15% since 11/15/24 |
| Low | 1.0100 on 11/22/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 1.3700 on 11/18/24 | 295.48 on 11/22/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.49 on 11/22/24 |
| 1-Month | |||||
| %Chg | -33.44% since 10/22/24 | -7.87% since 10/22/24 | +11.07% since 10/22/24 | -4.96% since 10/22/24 | +2.43% since 10/22/24 |
| Low | 1.0100 on 11/22/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 1.9891 on 11/11/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +30.66% since 08/22/24 | -9.25% since 08/22/24 | +23.06% since 08/22/24 | -5.95% since 08/22/24 | +18.98% since 08/22/24 |
| Low | 0.4500 on 09/26/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 1.9891 on 11/11/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -44.24% since 05/22/24 | -4.82% since 05/22/24 | +38.40% since 05/22/24 | +0.85% since 05/22/24 | +33.19% since 05/22/24 |
| Low | 0.4500 on 09/26/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 1.9891 on 11/11/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 65,250 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 63,350 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 5,490,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -50,730,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 3,340,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -8,660,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.80 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 11/14/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |